AndersonR. E., GeierT. J., & CahillS. P. (2016). Epidemiological associations between posttraumatic stress disorder and incarceration in the National Survey of American Life. Crim Behav Ment Health, 26(2), 110–123. doi:10.1002/cbm.1951.
2.
AndrewsJ. & KinnerS.A. (2012). Understanding drug-related mortality in released prisoners: A review of national coronial records. BMC Public Health, 12, 270. doi: 10.1186/1471-2458-12-270.
BaillargeonJ., GiordanoT. P., RichJ. D., WuZ. H., WellsK., PollockB. H., & PaarD. P. (2009). Accessing antiretroviral therapy following release from prison. JAMA, 301(8), 848–857. doi:10.1001/jama.2009.202.
5.
BanksD. & PlantyM. (2015). Assessment of Coverage in the Arrest-Related Deaths Program (Report No. NCJ 249099). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
6.
BanksD. & PlantyM. (2016). Arrest-Related Deaths Program Redesign Study, 2015–16: Preliminary Findings (Report No. NCJ 250112). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
7.
BarberC., AzraelD., CohenA., MillerM., ThymesD., WangD. E., & HemenwayD. (2016). Homicides by Police: Comparing Counts From the National Violent Death Reporting System, Vital Statistics, and Supplementary Homicide Reports. Am J Public Health, 106(5), 922–927. doi:10.2105/AJPH.2016.303074.
8.
BarkerE., KolvesK., & De LeoD. (2014). Management of suicidal and self-harming behaviors in prisons: systematic literature review of evidence-based activities. Arch Suicide Res, 18(3), 227–240. doi:10.1080/13811118.2013.824830.
9.
BeckA.J. (2015). Use of restrictive housing in US prisons and jails, 2011–12 (Report No. NCJ 249209). Washington DC: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
10.
BinswangerI. A., BlatchfordP. J., ForsythS. J., SternM. F., & KinnerS. A. (2016). Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort Study. Public Health Rep, 131(4), 574–582.
11.
BinswangerI. A., BlatchfordP. J., LindsayR. G., & SternM. F. (2011). Risk factors for all-cause, overdose and early deaths after release from prison in Washington state. Drug Alcohol Depend, 117(1), 1–6. doi:10.1016/j.drugalcdep.2010.11.029.
12.
BinswangerI. A., BlatchfordP. J., MuellerS. R., & SternM. F. (2013). Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med, 159(9), 592–600. doi:10.7326/0003-4819-159-9-201311050-00005.
13.
BinswangerI. A., CarsonE. A., KruegerP. M., MuellerS. R., SteinerJ. F., & SabolW. J. (2014). Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis. BMJ, 349, g4542. doi:10.1136/bmj.g4542.
14.
BinswangerI. A., KruegerP. M., & SteinerJ. F. (2009). Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health, 63(11), 912–919. doi:10.1136/jech.2009.090662.
15.
BinswangerI. A., NowelsC., CorsiK. F., GlanzJ., LongJ., BoothR. E., & SteinerJ. F. (2012). Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract, 7, 3. doi:10.1186/1940-0640-7–3.
16.
BinswangerI. A., NowelsC., CorsiK. F., LongJ., BoothR. E., KutnerJ., & SteinerJ. F. (2011). “From the prison door right to the sidewalk, everything went downhill,” a qualitative study of the health experiences of recently released inmates. Int J Law Psychiatry, 34(4), 249–255. doi:10.1016/j.ijlp.2011.07.002.
17.
BinswangerI. A., SternM. F., DeyoR. A., HeagertyP. J., CheadleA., ElmoreJ. G., & KoepsellT. D. (2007). Release from prison–a high risk of death for former inmates. N Engl J Med, 356(2), 157–165. doi:10.1056/NEJMsa064115.
18.
BinswangerI. A., SternM. F., YamashitaT. E., MuellerS. R., BaggettT. P., & BlatchfordP. J. (2016). Clinical risk factors for death after release from prison in Washington State: a nested case-control study. Addiction, 111(3), 499–510. doi:10.1111/add.13200.
19.
BirdS. M., & HutchinsonS. J. (2003). Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction, 98(2), 185–190.
20.
BirdS.M., McAuleyA., PerryS., & HunterC. (2016). Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006–10) versus after (2011–13) comparison. Addiction, 111(5), 883–91. doi: 10.1111/add.13265.
21.
BookerC. A., FlygareC. T., SolomonL., BallS. W., PustellM. R., BazermanL. B., … EnhanceLink StudyG. (2013). Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release. AIDS Behav, 17Suppl 2, S128–136. doi:10.1007/s10461-012-0354-3.
22.
BorschmannR., ThomasE., MoranP., CarrollM., HeffernanE., SpittalM.J., …, KinnerS.A. (2017). Self harm following release from prison: A prospective data linkage study. Aust N Z J Psychiatry, 51(3), 250–59. doi: 10.1177/0004867416640090.
23.
Brinkley-RubinsteinL. (2013). Incarceration as a catalyst for worsening health. Health & Justice, 1, 3. doi:10.1186/2194-7899-1-3.
24.
BruceR. D., & SchleiferR. A. (2008). Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention. Int J Drug Policy, 19(1), 17–23. doi:10.1016/j.drugpo.2007.11.019.
25.
BurchA. (2011). Arrest-Related Deaths, 2003–2009 -Statistical Tables (Report No. NCJ 235385). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
26.
CarsonE.A. & AndersonE. (2016). Prisoners in 2015 (Report No. NCJ 250229). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
27.
CASA. (2010). Behind Bars II: Substance Abuse and America's Prison Population. New York: The National Center on Addiction and Substance Abuse at Columbia University. Retreived from http://www.centeronaddiction.org/download/file/fid/487.
28.
ChandlerR. K., FletcherB. W., & VolkowN. D. (2009). Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA, 301(2), 183–190. doi:10.1001/jama.2008.976.
29.
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/.
30.
ChariK.A., SimonA.E., DeFrancesC.J, & MaruschakL. (2016). National Survey of Prison Health Care: Selected Findings (National Health Statistics Report, no. 96). Hyattsville, MD: National Center for Health Statistics.
De AndradeD, KinnerSA. (2016). A Systematic Review of Health and Behavioural Outcomes of Smoking Cessation Interventions in Prisons. Tob Control. [epub] doi: 10.1136/tobaccocontrol-2016-053297.
33.
DegenhardtL., LarneyS., KimberJ., GisevN., FarrellM., DobbinsT., … BurnsL. (2014). The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction, 109(8), 1306–1317. doi:10.1111/add.12536.
34.
FazelS., & BaillargeonJ. (2011). The health of prisoners. Lancet, 377(9769), 956–965. doi:10.1016/S0140-6736(10)61053-7.
35.
FazelS., CartwrightJ., Norman-NottA., & HawtonK. (2008). Suicide in prisoners: a systematic review of risk factors. J Clin Psychiatry, 69(11), 1721–1731.
FiscellaK., PlessN., MeldrumS., & FiscellaP. (2004). Alcohol and opiate withdrawal in US jails. Am J Public Health, 94(9), 1522–1524.
38.
FoxA. D., AndersonM. R., BartlettG., ValverdeJ., MacDonaldR. F., ShapiroL. I., & CunninghamC. O. (2014a). A description of an urban transitions clinic serving formerly incarcerated people. J Health Care Poor Underserved, 25(1), 376–382. doi:10.1353/hpu.2014.0039.
39.
FoxA. D., AndersonM. R., BartlettG., ValverdeJ., StarrelsJ. L., & CunninghamC. O. (2014b). Health outcomes and retention in care following release from prison for patient of an urban post- incarceration transitions clinic. J Health Care Poor Underserved, 25(3), 1139–1152. doi:10.1353/hpu.2014.0139.
40.
FoxA. D., MaradiagaJ., WeissL., SanchezJ., StarrelsJ. L., & CunninghamC. O. (2015). Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder. Addict Sci Clin Pract, 10, 2. doi:10.1186/s13722-014-0023-0.
41.
FrankJ. W., WangE. A., Nunez-SmithM., LeeH., & ComfortM. (2014). Discrimination based on criminal record and healthcare utilization among men recently released from prison: a descriptive study. Health Justice, 2, 6. doi:10.1186/2194-7899-2–6.
42.
GellerA., & CurtisM. A. (2011). A Sort of Homecoming: Incarceration and the housing security of urban men. Soc Sci Res, 40(4), 1196–1213. Ddoi:10.1016/j.ssresearch.2011.03.008.
43.
Glowa-KollischS., KabaF., WatersA., LeungY. J., FordE., & VentersH. (2016). From Punishment to Treatment: The “Clinical Alternative to Punitive Segregation” (CAPS) Program in New York City Jails. Int J Environ Res Public Health, 13(2), 182. doi:10.3390/ijerph13020182.
44.
GordonM. S., KinlockT. W., SchwartzR. P., FitzgeraldT. T., O'GradyK. E., & VocciF. J. (2014). A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry. Drug Alcohol Depend, 142, 33–40. doi:10.1016/j.drugalcdep.2014.05.011.
45.
GordonM. S., KinlockT. W., SchwartzR. P., & O'GradyK. E. (2008). A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction, 103(8), 1333–1342. doi:10.1111/j.1360-0443.2008.002238.x.
46.
HawksL., NortonB. L., CunninghamC. O., & FoxA. D. (2016). The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic. J Viral Hepat, 23(6), 473–478. doi:10.1111/jvh.12512.
47.
HeT., LiK., RobertsM. S., SpauldingA. C., AyerT., GrefenstetteJ. J., & ChhatwalJ. (2016). Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons. Ann Intern Med, 164(2), 84–92. doi:10.7326/M15-0617.
48.
HoJ. D., HeegaardW. G., DawesD. M., NatarajanS., ReardonR. F., & MinerJ. R. (2009). Unexpected arrest-related deaths in america: 12 months of open source surveillance. West J Emerg Med, 10(2), 68–73.
KabaF., LewisA., Glowa-KollischS., HadlerJ., LeeD., AlperH., … VentersH. (2014). Solitary confinement and risk of self-harm among jail inmates. Am J Public Health, 104(3), 442–447. doi:10.2105/AJPH.2013.301742.
51.
KaebleD & BonczarT.P. (2016). Probation and Parole in the United States, 2015 (Report No. NCJ 250230). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
52.
KariminiaA., ButlerT., CorbenS., LevyM., GrantL., KaldorJ., & LawM. (2007). Extreme cause-specific mortality in a cohort of adult prisoners–1988 to 2002: a data-linkage study. Int J Epidemiol, 36(2), 310–316. doi:10.1093/ije/dyl225.
53.
KariminiaA., LawM. G., ButlerT. G., CorbenS. P., LevyM. H., KaldorJ. M., & GrantL. (2007). Factors associated with mortality in a cohort of Australian prisoners. Eur J Epidemiol, 22(7), 417–428. doi:10.1007/s10654-007-9134-1.
54.
KariminiaA., LawM. G., ButlerT. G., LevyM. H., CorbenS. P., KaldorJ. M., & GrantL. (2007). Suicide risk among recently released prisoners in New South Wales, Australia. Med J Aust, 187(7), 387–390.
55.
KinnerS.A. (2010). Understanding mortality and health outcomes for ex-prisoners: First steps on a long road. Addiction. 2010;105(9),1555–6.
56.
KinnerS. A & BinswangerI. A. (2014). Mortality after release from prison. In BruinsmaG. & WeisburdD. (Ed.), Encyclopedia of Criminology and Criminal Justice. doi: 10.1007/978-1-4614-5690-2_332.
57.
KinnerS.A., DegenhardtL., CoffeyC., HearpsS., SpittalM., SawyerS., PattonG.C. (2015) Substance use and risk of death in young offenders: A prospective data linkage study. Drug Alcohol Rev, 34(1), 46–50. doi: 10.1111/dar.12179.
58.
KinnerS.A., ForsythS. (2016). Development and validation of a national system for routinemonitoring of mortality in people recently released from prison. PLOS ONE. 11(6):e0157328.
59.
KinnerS.A., ForsythS., & WilliamsG.M. (2013). Systematic review of record linkage studies of mortality in ex-prisoners: Why (good) methods matter. Addiction, 108(1), 38–49. doi: 10.1111/add.12010.
60.
KrinskyC. S., LathropS. L., BrownP., & NolteK. B. (2009). Drugs, detention, and death: a study of the mortality of recently released prisoners. Am J Forensic Med Pathol, 30(1), 6–9. doi:10.1097/PAF.0b013e3181873784.
61.
LarneyS., & DolanK. (2009). A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?Eur Addict Res, 15(2), 107–112. doi:10.1159/000199046.
62.
LeeJ. D., McDonaldR., GrossmanE., McNeelyJ., LaskaE., RotrosenJ., & GourevitchM. N. (2015). Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial. Addiction, 110(6), 1008–1014. doi:10.1111/add.12894.
63.
LimS., SeligsonA. L., ParvezF. M., LutherC. W., MavinkurveM. P., BinswangerI. A., & KerkerB. D. (2012). Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001–2005. Am J Epidemiol, 175(6), 519–526. doi:10.1093/aje/kwr327.
64.
LincolnT., TuthillR. W., RobertsC. A., KennedyS., HammettT. M., Langmore-AvilaE., & ConklinT. J. (2009). Resumption of smoking after release from a tobacco-free correctional facility. J Correct Health Care, 15(3), 190–196. doi:10.1177/1078345809333388.
65.
MarsdenJ., StillwellG., JonesH., CooperA., EastwoodB., FarrellM., … HickmanM. (2017). Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. doi:10.1111/add.13779.
66.
MartinS.S., ButzinC.A., SaumC.A., & InciardiJ.A. (1999). Three-Year Outcomes of Therapeutic Community Treatment for Drug-Involved Offenders in Delaware: From Prison to Work Release to Aftercare. The Prison Journal, 79(3), 294–320.
67.
MaruschakL.M., BerzofskyM., & UnangstJ. (2015). Medical Problems of State and Federal Prisoners and Jail Inmates, 2011–12 (Report No. NCJ 248491). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
68.
MerrallE. L., KariminiaA., BinswangerI. A., HobbsM. S., FarrellM., MarsdenJ., … BirdS. M., (2010). Meta-analysis of drug-related deaths soon after release from prison. Addiction, 105(9), 1545–1554. doi:10.1111/j.1360-0443.2010.02990.x.
69.
MeyerJ. P., CepedaJ., WuJ., TrestmanR. L., AlticeF. L., & SpringerS. A. (2014). Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med, 174(5), 721–729. doi:10.1001/jamainternmed.2014.601.
70.
MintonT.D. & ZengZ. (2016). Jail inmates in 2015 (Report No. NCJ 250394). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
71.
MumolaC.J. & KarbergJ.C. (2006). Drug Use and Dependence, State and Federal Prisoners, 2004 (Report No. NCJ 213530). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
72.
MumolaC.J. (2007). Medical causes of death in state prisons, 2001–2004 (Report No. NCJ 216340). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
73.
NoonanM. (2010). Mortality in local jails, 2000–2007 (Report No. NCJ 222988). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
74.
NoonanM., RohloffH., & GinderS. (2015). Mortality in Local Jails and State Prisons, 2000–2013 - Statistical Tab (Report No. NCJ 248756). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
75.
NoonanM.E. (2016a). Mortality in State Prisons, 2001–2014 – Statistical Tables (Report No. NCJ 250150). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
76.
NoonanM.E. (2016b). Mortality in Local Jails, 2001–2014 – Statistical Tables (Report No. NCJ 250169). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
77.
NunnA., ZallerN., DickmanS., TrimburC., NijhawanA., & RichJ. D. (2009). Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend, 105(1–2), 83–88. doi:10.1016/j.drugalcdep.2009.06.015.
78.
NurcoD. N., HanlonT. E., BatemanR. W., & KinlockT. W. (1995). Drug abuse treatment in the context of correctional surveillance. J Subst Abuse Treat, 12(1), 19–27.
79.
PattersonE. J. (2010). Incarcerating death: mortality in U.S. state correctional facilities, 1985–1998. Demography, 47(3), 587–607.
80.
PattersonE. J. (2013). The dose-response of time served in prison on mortality: New York State, 1989–2003. Am J Public Health, 103(3), 523–528. doi:10.2105/AJPH.2012.301148.
81.
PrattD., PiperM., ApplebyL., WebbR., & ShawJ. (2006). Suicide in recently released prisoners: a population-based cohort study. Lancet, 368(9530), 119–123. doi:10.1016/S0140-6736(06)69002-8.
82.
PritchardC., CoxM., & DawsonA. (1997). Suicide and ‘violent’ death in a six-year cohort of male probationers compared with pattern of mortality in the general population: evidence of accumulative socio-psychiatric vulnerability. J R Soc Health, 117(3), 180–185.
83.
Reingle GonzalezJ. M., & ConnellN. M. (2014). Mental health of prisoners: identifying barriers to mental health treatment and medication continuity. Am J Public Health, 104(12), 2328–2333. doi:10.2105/AJPH.2014.302043.
84.
RosenD. L., SchoenbachV. J., & WohlD. A. (2008). All- cause and cause-specific mortality among men released from state prison, 1980–2005. Am J Public Health, 98(12), 2278–2284. doi:10.2105/AJPH.2007.121855.
85.
RosenD. L., WohlD. A., & SchoenbachV. J. (2011). All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995–2005. Ann Epidemiol, 21(10), 719–726. doi:10.1016/j.annepidem.2011.04.007.
SeamanS. R., BrettleR. P., & GoreS. M. (1998). Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ, 316(7129), 426–428.
88.
SeymourA., OliverJ. S., & BlackM. (2000). Drug-related deaths among recently released prisoners in the Strathclyde Region of Scotland. J Forensic Sci, 45(3), 649–654.
89.
SpauldingA. C., SealsR. M., McCallumV. A., PerezS. D., BrzozowskiA. K., & SteenlandN. K. (2011). Prisoner survival inside and outside of the institution: implications for health-care planning. Am J Epidemiol, 173(5), 479–487. doi:10.1093/aje/kwq422.
90.
SpittalM.J., ForsythS., PirkisJ., AlatiR., KinnerS.A. (2014). Suicide in adults released from prison in Queensland, Australia: a cohort study. J Epidemiol Community Health, 68(10):993–8. doi: 10.1136/jech-2014-204295.
91.
SpringerS. A., PesantiE., HodgesJ., MacuraT., DorosG., & AlticeF. L. (2004). Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis, 38(12), 1754–1760. doi:10.1086/421392.
92.
StrangJ., McCambridgeJ., BestD., BeswickT., BearnJ., ReesS., & GossopM. (2003). Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ, 326(7396), 959–960. doi:10.1136/bmj.326.7396.959.
93.
TeixeiraP. A., JordanA. O., ZallerN., ShahD., & VentersH. (2015). Health outcomes for HIV-infected persons released from the New York City jail system with a transitional care-coordination plan. Am J Public Health, 105(2), 351–357. doi:10.2105/AJPH.2014.302234.
94.
TeplinL.A., JakubowskiJ.A., AbramK.M., OlsonN.D., StokesM.L., WeltyL.J. (2014). Firearm Homicide and Other Causes of Death in Delinquents: A 16–Year Prospective Study. Pediatrics, 134(1):63–73. doi: 10.1542/peds.2013–3966.
95.
ThomasE. H., WangE. A., CurryL. A., & ChenP. G. (2016). Patients' experiences managing cardiovascular disease and risk factors in prison. Health Justice, 4, 4. doi:10.1186/s40352-016-0035-9.
96.
van OlphenJ., FreudenbergN., FortinP., & GaleaS. (2006). Community reentry: perceptions of people with substance use problems returning home from New York City jails. Journal of Urban Health, 83(3), 372–381. doi:10.1007/s11524-006-9047-4.
97.
VergerP., RotilyM., PrudhommeJ., & BirdS. (2003). High mortality rates among inmatesduring the year following their discharge from a French prison. J Forensic Sci, 48(3), 614–616.
98.
WakemanS. E., BowmanS. E., McKenzieM., JeronimoA., & RichJ. D. (2009). Preventing death among the recently incarcerated: an argument for naloxone prescription before release. J Addict Dis, 28(2), 124–129. doi:10.1080/10550880902772423.
99.
WakemanS. E., McKinneyM. E., & RichJ. D. (2009). Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med, 24(7), 860–862. doi:10.1007/s11606-009-0977-x.
100.
WakemanS. E., & RichJ. D. (2015). Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care. J Addict Dis, 34(2–3), 220–225. doi:10.1080/10550887.2015.1059217.
101.
WangE. A., HongC. S., SamuelsL., ShavitS., SandersR., & KushelM. (2010). Transitions clinic: creating a community-based model of health care for recently released California prisoners. Public Health Rep, 125(2), 171–177.
102.
WangE. A., HongC. S., ShavitS., SandersR., KessellE., & KushelM. B. (2012). Engaging individuals recently released from prison into primary care: a randomized trial. Am J Public Health, 102(9), e22–29. doi:10.2105/AJPH.2012.300894.
103.
WangE. A., PletcherM., LinF., VittinghoffE., KerteszS. G., KiefeC. I., & Bibbins-DomingoK. (2009). Incarceration, incident hypertension, and access to health care: findings from the coronary artery risk development in young adults (CARDIA) study. Arch Intern Med, 169(7), 687–693. doi:10.1001/archinternmed.2009.26.
104.
WangE. A., WhiteM. C., JamisonR., GoldensonJ., EstesM., & TulskyJ. P. (2008). Discharge planning and continuity of health care: findings from the San Francisco County Jail. Am J Public Health, 98(12), 2182–2184. doi:10.2105/AJPH.2007.119669.
WilperA. P., WoolhandlerS., BoydJ. W., LasserK. E., McCormickD., BorD. H., & HimmelsteinD. U. (2009). The health and health care of US prisoners: results of a nationwide survey. Am J Public Health, 99(4), 666–672. doi:10.2105/AJPH.2008.144279.
108.
ZakariaS., JohnsonE. N., HayashiJ. L., & ChristmasC. (2015). Graduate Medical Education in the Freddie Gray Era. N Engl J Med, 373(21), 1998–2000. doi:10.1056/NEJMp1509216.
109.
ZallerN. D., HolmesL., DylA. C., MittyJ. A., BeckwithC. G., FlaniganT. P., & RichJ. D. (2008). Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved, 19(2), 522–531. doi:10.1353/hpu.0.0030.
110.
ZengZ., BinswangerI., BlatchfordP., & Smiley-McDonaldH. (2016). Assessing inmate cause of death: deaths in custody reporting program and national death index (Report No. NCJ 249568). Washington D.C.: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
111.
ZuckerH., AnnucciA. J., StancliffS., & CataniaH. (2015). Overdose prevention for prisoners in New York: a novel program and collaboration. Harm Reduct J, 12, 51. doi:10.1186/s12954-015-0084-8.